NDC 70518-3010-1 - Latuda
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3010
- Requested NDC
- 70518-3010-1
- Package NDCs from labels
- 70518-3010-1, 70518-3010-0
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2021-02-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Latuda - REMEDYREPACK INC. | REMEDYREPACK INC. | 2021-02-03 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3010 | LATUDA (LURASIDONE HYDROCHLORIDE) TABLET, FILM COATED [REMEDYREPACK INC.] | 1 | Legacy NDC | 20210204_2a26c9b9-4436-48b2-9c5d-d0af4500ad57.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Latuda | LURASIDONE HYDROCHLORIDE | Sumitomo Pharma America, Inc. | afad3051-9df2-4c54-9684-e8262a133af8 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | NDA200603 63402-308 1235249 1040041 1040043 1431237 1297357 1040031 1040036 1297278 1431235 1235247 7383b0e0-01e8-4778-96f0-6f2e0c9586ae afad3051-9df2-4c54-9684-e8262a133af8 O0P4I5851I |
| lurasidone hydrochloride | LURASIDONE HYDROCHLORIDE | NorthStar RxLLC | 10a88607-0b5e-4707-b0cb-40c58a5c6774 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 1040041 1040031 1431235 1235247 O0P4I5851I |
| Lurasidone Hydrochloride | LURASIDONE HYDROCHLORIDE | American Health Packaging | b83e1015-8016-4c7c-8239-8dba3a882e46 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 1040041 1040031 1431235 1235247 O0P4I5851I |
| Lurasidone HCL | LURASIDONE HCL | Direct_rx | 296811cf-cba8-16c2-e063-6294a90acfa6 | 2024-12-16 | Boxed warning, Warnings, Adverse reactions | 1040031 O0P4I5851I |
| Lurasidone hydrochloride | LURASIDONE HYDROCHLORIDE | Zydus Lifesciences Limited | 0f5f8228-1304-4981-8577-029136627260 | 2024-11-30 | 1040041 1040031 1297278 1431235 1235247 O0P4I5851I | |
| Lurasidone Hydrochloride | LURASIDONE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | 84648adf-b3c6-476e-8d11-2a9d7c5eb550 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 1040041 1040031 1297278 1431235 1235247 O0P4I5851I |
| lurasidone hydrochloride | LURASIDONE HYDROCHLORIDE | A-S Medication Solutions | c96cbfc9-773b-410a-ada3-2822cbd58f8f | 2024-05-20 | Boxed warning, Warnings, Adverse reactions | 1235247 O0P4I5851I |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| lurasidone hydrochloride | LURASIDONE HYDROCHLORIDE | A-S Medication Solutions | b848e6f3-63c0-4d2e-bda5-c9e961472092 | 2024-02-07 | Boxed warning, Warnings, Adverse reactions | 1235247 O0P4I5851I |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| lurasidone hydrochloride | LURASIDONE HYDROCHLORIDE | MAJOR PHARMACEUTICALS | cecfd4c8-bff3-44fa-b360-b3e8a8e955f5 | 2023-12-28 | Boxed warning, Warnings, Adverse reactions | 1040041 1040031 1297278 1431235 1235247 O0P4I5851I |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| lurasidone hydrochloride | LURASIDONE HYDROCHLORIDE | A-S Medication Solutions | 3cd2da15-4d51-4e5c-b683-1936dc19e234 | 2023-04-26 | Boxed warning, Warnings, Adverse reactions | 1235247 O0P4I5851I |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| f6e15682-23e0-13a6-e053-6394a90a734c | 2a26c9b9-4436-48b2-9c5d-d0af4500ad57 | 2023-03-14 | Boxed warning, Warnings, Adverse reactions | 2a26c9b9-4436-48b2-9c5d-d0af4500ad57 | ||
| Lurasidone Hydrochloride | LURASIDONE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 27f70e15-ee22-47ae-ba87-20e2b4a1a4d6 | 2023-01-25 | Boxed warning, Warnings, Adverse reactions | 1040041 1040031 1297278 1431235 1235247 O0P4I5851I |
| Lurasidone Hydrochloride | LURASIDONE HYDROCHLORIDE | Dr. Reddys Laboratories Inc | 2f22a0bd-94f3-53d7-717c-03da8e1a7e97 | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | 1297278 O0P4I5851I |
| lurasidone hydrochloride | LURASIDONE HYDROCHLORIDE | Ascend Laboratories, LLC | 36b6bacd-ac11-493b-a8a4-8dad448ed9d5 | 2023-01-06 | Boxed warning, Warnings, Adverse reactions | 1040041 1040031 1297278 1431235 1235247 O0P4I5851I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.